BioPharmSignal logoBioPharmSignal

Biotech News

Aquestive Therapeutics to Report Fourth Quarter 2025 Financial Results and Recent Business Highlights on March 4 and Host Conference Call on March 5 at 8:00 a.m. ET

Aquestive Therapeutics (AQST)Aquestive TherapeuticsEarnings

WARREN, N.J., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced that it

Related news

AQSTAquestive Therapeutics2026-07-29 11:00 EST

Aquestive Therapeutics to Report Second Quarter 2026 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET

AQSTAquestive Therapeutics2026-05-06 11:00 EST

Aquestive Therapeutics to Report First Quarter 2026 Financial Results and Recent Business Highlights on May 13 and Host Conference Call on May 14 at 8:00 a.m. ET

View all latest news

Aquestive Therapeutics

Oral Film Drug Delivery Company Aquestive Therapeutics develops medicines using proprietary film-based delivery technologies for allergic reactions and other conditions. Anaphylm Anaphylm is a postage-stamp-sized sublingual film containing a prodrug of epinephrine for severe allergic reactions, including anaphylaxis. It dissolves without...

Recent company news

AQSTAquestive Therapeutics2026-07-29 11:00 EST

Aquestive Therapeutics to Report Second Quarter 2026 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET

AQSTAquestive Therapeutics2026-07-07 11:00 EST

Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism

AQSTAquestive Therapeutics2026-05-13 20:01 EST

Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

AQSTAquestive Therapeutics2026-05-12 13:32 EST

Aquestive Therapeutics Completes $150 Million Debt Refinancing with Oaktree

AQSTAquestive Therapeutics2026-05-06 11:00 EST

Aquestive Therapeutics to Report First Quarter 2026 Financial Results and Recent Business Highlights on May 13 and Host Conference Call on May 14 at 8:00 a.m. ET

Stock data

Close
3.92 USD
Market cap
493.02M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States